Yes, but observe that the data in the image includes only "cases" with no discrimination for their severity. (I'm saying this because Ivory Hecker was once a Fox 26 reporter, [supposedly](https://www.chron.com/culture/tv/article/Fox-26-Ivory-Hecker-recordings-hydroxychloroquine-16251044.php) dismissed for her bias/promotion of hydroxychloroquine [and of [Stella Immanuel](https://en.wikipedia.org/wiki/Stella_Immanuel)], among other things.)

The low/waning efficacy of the Pfizer vaccine purely in terms of cases in Israel has been covered the mainstream press as well, e.g. [CNBC on July 23](https://www.cnbc.com/2021/07/23/delta-variant-pfizer-covid-vaccine-39percent-effective-in-israel-prevents-severe-illness.html).

> Pfizer and BioNTech’s Covid-19 vaccine is just 39% effective in Israel where the delta variant is the dominant strain, according to a new report from the country’s Health Ministry.
>
> The two-dose vaccine still works very well in preventing people from getting seriously sick, demonstrating 88% effectiveness against hospitalization and 91% effectiveness against severe illness, according to the Israeli data.

100% of the fully sequenced cases in Israel [have been](https://www.cnbc.com/2021/08/06/covid-charts-show-how-far-delta-variant-has-spread-around-the-world.html) the delta variant in the past month [July]. Also, at the end of July, Israel has [announced](https://www.cnbc.com/2021/07/29/delta-variant-israel-to-give-pfizer-covid-booster-shots-to-elderly-.html) [3rd] booster shots for the elderly who had their last vaccine dose 5 months before.

Preliminary data from a [US study](https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v1.full.pdf) [preprint] (covered by the press today/yesterday), paints a somewhat similar picture.

>  Both
vaccines [Pfizer=BNT162b2; Moderna=mRNA-1273] were highly effective during this study period against SARS-CoV-2 infection
(mRNA-1273: 86%, 95%CI: 81-90.6%; BNT162b2: 76%, 95%CI: 69-81%) and COVID-19
associated hospitalization (mRNA-1273: 91.6%, 95% CI: 81-97%; BNT162b2: 85%, 95% CI:
73-93%). However, in July, the effectiveness against infection was considerably lower for
mRNA-1273 (76%, 95% CI: 58-87%) with an even more pronounced reduction in
effectiveness for BNT162b2 (42%, 95% CI: 13-62%).

(More [newsworthy](https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-may-be-superior-pfizer-against-delta-breakthrough-odds-rise-with-time-2021-08-09/) was the fact that this latter study suggests  Moderna offered substantially more protection than Pfizer against mere infection, in multiple US states.)